Vivus (VVUS)
Create an Alert
14.18
+0.42 +3.05%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Vivus Revenue Quarterly YoY Growth
Vivus Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 30, 2010 | -100.0% |
| March 31, 2010 | -100.0% |
| Dec. 31, 2009 | -100.0% |
| Sept. 30, 2009 | -100.0% |
| June 30, 2009 | -41.73% |
| March 31, 2009 | -2.01% |
| Dec. 31, 2008 | -3.43% |
| Sept. 30, 2008 | 33.47% |
| June 30, 2008 | 516.6% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
| June 30, 2000 | Go Pro |
| March 31, 2000 | Go Pro |
| Dec. 31, 1999 | Go Pro |
| Sept. 30, 1999 | Go Pro |
| June 30, 1999 | Go Pro |
| March 31, 1999 | Go Pro |
| Dec. 31, 1998 | Go Pro |
| Sept. 30, 1998 | Go Pro |
| June 30, 1998 | Go Pro |
| March 31, 1998 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
VVUS Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Arena Pharmaceuticals | 8.41% |
| Orexigen Therapeutics | 0.00% |
| XOMA | -4.18% |
VVUS Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -100.0% | Sep 2009 |
| Maximum | 516.6% | Jun 2008 |
| Average | 11.44% |
